2014-04-30 15:38:01 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to CVS Caremark Corporation (CVS) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering CVS Caremark Corporation (CVS). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential CVS Caremark Corporation investor.
Report Summary: CVS Caremark Corporation is an above average quality company with a neutral outlook. CVS Caremark Corporation has medium business growth and is run by efficient management. The trend in CVS Caremark Corporation fair value exchange rate against its closest rated-competitor, Express Scripts Holding Co, has been stable over the past 2 weeks. When compared to its closest competitor, CVS Caremark Corporation shows similar overvaluation and is equally likely to outperform the market.
The report breaks down the Total StockMark into
its three components - business, management and price, performing an in-depth analysis of CVS Caremark Corporation for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering 31 different markets and over 22,000 companies. The StockMarks rating system is based on proven investment principles and is designed to drive long-term shareholder returns.